# Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients

> **NCT02303327** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Sir Mortimer B. Davis - Jewish General Hospital** · enrollment: 307 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** EBRT + HDR brachytherapy boost
- **RADIATION:** Hypofractionated Dose Escalation Radiotherapy
- **DRUG:** Androgen deprivation therapy

## Key facts

- **NCT ID:** NCT02303327
- **Lead sponsor:** Sir Mortimer B. Davis - Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-01
- **Primary completion:** 2026-12
- **Final completion:** 2029-01
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02303327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02303327, "Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02303327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*